How to get the EU Digital COVID Certificate in Croatia, The vaccine passport in Croatia

How to get the EU Digital COVID Certificate in Croatia, The vaccine passport in Croatia

Get your NHS COVID Pass, COVID certificate for NI residents, Traveling to EU With NHS COVID Certificate, Der Grüne Pass, COVID Passport for Austria, Austria’s vaccine passport, Digital COVID Certificates, Croatia Vaccine Passport, Croatia COVID Pass, How to get the EU Digital COVID Certificate in Croatia, The vaccine passport in Croatia etc

Buy a COVID-19 Vaccination Record COVID Certificate in Croatia
Buy a COVID-19 Vaccination Record  COVID Certificate in Croatia

Information on how well the vaccine works

  • Based on evidence from clinical trials, the Moderna vaccine was 94.1% effective at preventing laboratory-confirmed COVID-19 illness in people who received two doses who had no evidence of being previously infected.
  • The vaccine appeared to have high effectiveness in clinical trials (efficacy) among people of diverse age, sex, race, and ethnicity categories and among persons with underlying medical conditions.
  • Although few people in the clinical trials were admitted to the hospital, this happened less often in the people who got the Moderna vaccine compared to people who got the saline placebo.
  • CDC will continue to provide updates as we learn more about how well the Moderna vaccine works in real-world conditions.

Demographic information from clinical trials

Clinical trials for the Moderna vaccine included people from the following racial and ethnic categories:

  • 79.4% White
  • 20% Hispanic/Latino
  • 9.7% African American
  • 4.7% Asian
  • <3% other races/ethnicities

Age and sex breakdown:

  • 52.6% male
  • 47.4% female
  • 25.3% 65 years and older

Most people who participated in the trials (82%) were considered to have an occupational risk of exposure, with 25.4% of them being healthcare workers.

Among people who participated in the clinical trials, 22.3% had at least one high-risk condition, which included lung disease, heart disease, obesity, diabetes, liver disease, or HIV infection. Four percent (4%) of participants had two or more high-risk conditions